Page Tools:
  • print-friendly version

Dx/Rx : Brain Tumors

Author(s): Eudocia Quant, MD, Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts
Details:
  • ISBN-13: 9780763773724
  • Paperback    214 pages      © 2011
Price: International Sales $49.95 US List
Add to Cart

Overview

Written by a medical oncologist, Dx/Rx: Brain Tumors is a concise, pocket-sized guide that provides essential information on the diagnosis and management of brain tumors. From tumors affecting the central and peripheral nervous systems to neurologic complications of cancer and cancer therapies, it covers the major topics in neuro-oncology and is ideal for internists, neurologists, and oncologists. It is a must-have reference for on the ward or in the clinic!

Key features include:

  • Up-to-date review of major topics in neuro-oncology, presented in a concise, easy-to-read format
  • In-depth discussion of tumors affecting the central and peripheral nervous systems, such as gliomas, meningiomas, brain  metastases and neoplastic meningitis
  • Treatment strategies for the most common tumors
  • Essential information about neurologic complications of cancer and cancer therapies, including cognitive impairment from chemotherapy and radiation, peripheral neuropathy, paraneoplastic disorders, strokes and seizures

ShowTable of Contents

Chapter  1  Primary Brain Tumors
Chapter  2  Brain Metastases
Chapter  3  Spinal Tumors
Chapter  4  Leptomeningeal Metastases
Chapter  5  Neurologic Complications of Radiation Therapy
Chapter  6  Neurologic Complications of Chemotherapy
Chapter  7  Paraneoplastic Disorders
Chapter  8  Cerebrovascular Complications
Chapter  9  Medical Complications of Brain Tumor Patients
Back to top

ShowAbout the Author(s)

Eudocia Quant, MD-Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts

Dr. Eudocia Quant earned her medical degree from Washington University School of Medicine in 2003. She subsequently completed her residency in neurology at the combined Brigham and Women's/Masschusetts General Hospital program and her fellowship in neuro-oncology at Dana Farber Cancer Institute/Massachusetts General Hospital. Following fellowship, she joined the faculty at Dana Farber. Dr. Quant is board certified in neurology. Her clinical and research interest include biomarkers in glioblastomas, brain metastases and neurologic complications of cancer.

Back to top

ShowReviews

  • This book will prove useful as a concise and portable reference on tumors and cancer complications affecting the nervous system.  Residents could find this book especially useful in preparation for board exams and in their daily care of patients.

    Kristine Ziemba,  MD, PhD
    Mayo Clinic Hospital

Back to top